BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32396854)

  • 21. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
    Sugimoto T; Watanabe T
    J Clin Exp Hematop; 2016; 56(1):1-19. PubMed ID: 27334853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
    Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
    Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biology of follicular lymphoma: insights and windows of clinical opportunity.
    Perrett M; Edmondson C; Okosun J
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):688-694. PubMed ID: 36485095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
    Kumar E; Pickard L; Okosun J
    Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell migration patterns and ongoing somatic mutations in the progression of follicular lymphoma.
    Adam P; Schoof J; Hartmann M; Schwarz S; Puppe B; Ott M; Rosenwald A; Ott G; Muller-Hermelink HK
    Cytogenet Genome Res; 2007; 118(2-4):328-36. PubMed ID: 18000387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The biology of the germinal center.
    Natkunam Y
    Hematology Am Soc Hematol Educ Program; 2007; ():210-5. PubMed ID: 18024632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
    Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
    Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-cell profiling reveals a memory B cell-like subtype of follicular lymphoma with increased transformation risk.
    Wang X; Nissen M; Gracias D; Kusakabe M; Simkin G; Jiang A; Duns G; Sarkozy C; Hilton L; Chavez EA; Segat GC; Wong R; Kim J; Aoki T; Islam R; May C; Hung S; Tyshchenko K; Brinkman RR; Hirst M; Karsan A; Freeman C; Sehn LH; Morin RD; Roth AJ; Savage KJ; Craig JW; Shah SP; Steidl C; Scott DW; Weng AP
    Nat Commun; 2022 Nov; 13(1):6772. PubMed ID: 36351924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression.
    Han G; Deng Q; Marques-Piubelli ML; Dai E; Dang M; Ma MCJ; Li X; Yang H; Henderson J; Kudryashova O; Meerson M; Isaev S; Kotlov N; Nomie KJ; Bagaev A; Parra ER; Solis Soto LM; Parmar S; Hagemeister FB; Ahmed S; Iyer SP; Samaniego F; Steiner R; Fayad L; Lee H; Fowler NH; Flowers CR; Strati P; Westin JR; Neelapu SS; Nastoupil LJ; Vega F; Wang L; Green MR
    Blood Cancer Discov; 2022 Sep; 3(5):428-443. PubMed ID: 35687817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multi-omic profiling of follicular lymphoma reveals changes in tissue architecture and enhanced stromal remodeling in high-risk patients.
    Radtke AJ; Postovalova E; Varlamova A; Bagaev A; Sorokina M; Kudryashova O; Meerson M; Polyakova M; Galkin I; Svekolkin V; Isaev S; Wiebe D; Sharun A; Sarachakov A; Perelman G; Lozinsky Y; Yaniv Z; Lowekamp BC; Speranza E; Yao L; Pittaluga S; Shaffer AL; Jonigk D; Phelan JD; Davies-Hill T; Huang DW; Ovcharov P; Nomie K; Nuzhdina E; Kotlov N; Ataullakhanov R; Fowler N; Kelly M; Muppidi J; Davis JL; Hernandez JM; Wilson WH; Jaffe ES; Staudt LM; Roschewski M; Germain RN
    Cancer Cell; 2024 Mar; 42(3):444-463.e10. PubMed ID: 38428410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
    Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
    Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
    [No Abstract]   [Full Text] [Related]  

  • 33. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.
    Küppers R; Sousa AB; Baur AS; Strickler JG; Rajewsky K; Hansmann ML
    Mol Med; 2001 May; 7(5):285-92. PubMed ID: 11474574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformed follicular lymphoma.
    Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
    Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas.
    Said JW; Pinkus JL; Shintaku IP; deVos S; Matsumura F; Yamashiro S; Pinkus GS
    Mod Pathol; 1998 Jan; 11(1):1-5. PubMed ID: 9556415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of factors affecting the onset and maturation course of follicular lymphoma through simulations of the germinal center.
    Fenwick MK; Escobedo FA
    Bull Math Biol; 2009 Aug; 71(6):1432-62. PubMed ID: 19412639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular pathogenesis of follicular lymphoma.
    Kishimoto W; Nishikori M
    J Clin Exp Hematop; 2014; 54(1):23-30. PubMed ID: 24942943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of follicular lymphoma to diffuse large B-cell lymphoma proceeds by distinct oncogenic mechanisms.
    Davies AJ; Rosenwald A; Wright G; Lee A; Last KW; Weisenburger DD; Chan WC; Delabie J; Braziel RM; Campo E; Gascoyne RD; Jaffe ES; Muller-Hermelink K; Ott G; Calaminici M; Norton AJ; Goff LK; Fitzgibbon J; Staudt LM; Andrew Lister T
    Br J Haematol; 2007 Jan; 136(2):286-93. PubMed ID: 17278262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma.
    Desmots F; Roussel M; Pangault C; Llamas-Gutierrez F; Pastoret C; Guiheneuf E; Le Priol J; Camara-Clayette V; Caron G; Henry C; Belaud-Rotureau MA; Godmer P; Lamy T; Jardin F; Tarte K; Ribrag V; Fest T
    Clin Cancer Res; 2019 Jan; 25(2):735-746. PubMed ID: 30348636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
    Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
    Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.